Baird Reiterates Neutral Rating on UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH)

Market Context

UNITEDHEALTH GROUP INCORPORATED (Delaware) operates in the Healthcare sector. The stock currently trades at $395.62 with a market capitalization of $305.0B. The stock has gained 13.8% over the past 52 weeks.

Analyst coverage from Baird provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for UNITEDHEALTH GROUP INCORPORATED (Delaware).

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for UNITEDHEALTH GROUP INCORPORATED (Delaware)

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 14, 2026	Piper Sandler	Overweight	N/A
Oct 14, 2026	Barclays	Overweight	N/A
Oct 14, 2026	Baird	Neutral	N/A
Oct 09, 2026	TD Cowen	Hold	N/A
Jul 21, 2026	Mizuho	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View UNH Stock Page